authorization in the second half of November https://www.lapresse.ca/actualites/sciences/2020-10-23/covid-19/reprise-de-deux-essais-de-vaccins-aux-etats-unis.php
The two leading candidates are those of Pfizer and Moderna: the American companies plan to apply for an authorization in the second half of November; the FDA did not say how soon it would give its opinion afterwards, but it could come well before the end of December.